JORNAY PM
KNIGHT THERAPEUTICS INC.
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of JORNAY PM in Canada?
A shortage of JORNAY PM 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 13, 2026), but it has not started yet.
Why is JORNAY PM not available?
The reason the manufacturer reported: Demand increase for the drug.
When will JORNAY PM be available again?
The manufacturer's estimated resolution date is October 1, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
ADHD Medication Shortage in Canada: What to Know
Why ADHD medications go into shortage in Canada more often than most drug classes, which ones are most affected, and what to do if yours is short-supplied.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
PHL-METHYLPHENIDATE
PHARMEL INC
METHYLPHENIDATE TAB 20MG
TECHNILAB PHARMA INC.
AA-METHYLPHENIDATE SR
Extended-ReleaseAA PHARMA INC
PMS-METHYLPHENIDATE
PHARMASCIENCE INC
METHYLPHENIDATE TAB 10MG
TECHNILAB PHARMA INC.
RATIO-METHYLPHENIDATE
TEVA CANADA LIMITED
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
DIN
02553074
Strength
20MG
Dosage Form
CAPSULE (DELAYED- AND EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from KNIGHT THERAPEUTICS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02468735
0.5MG · DIN 02381729
0.25MG · DIN 02381710
DIN 02332450
1G · DIN 02242980
DIN 02505223
400MG · DIN 02245828
30MG · DIN 02296152
DIN 02290308
25MG · DIN 01997602
20MG · DIN 01997572
5MG · DIN 01924516